Medical News

RSS

Cardio Vascular Medical Device releases shareholders update

Cardio Vascular Medical Device Corp., a leading developer of advanced cardiovascular surgery technology, today released a brief shareholders update.

26 Oct 2009

Wound Management Technologies signs distribution agreement with Biocure S.r.l. of Milan

Wound Management Technologies, Inc., through its subsidiary, Wound Care Innovations, announced today that it has reached an agreement with Biocure S.r.l. of Milan, Italy for the distribution of WNDM's patented molecular form of activated collagen, CellerateRx®.

26 Oct 2009

Cephalon, BDC sign option agreement

Cephalon, Inc. and BioAssets Development Corporation (BDC), a privately held biopharmaceutical company, today announced that the companies have signed an agreement that will provide Cephalon with an option to acquire BDC.

26 Oct 2009

Thermo Fisher Scientific announces the availability of its Copeptin assay in Europe

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the availability in Europe of its new Copeptin assay, which helps medical personnel quickly and accurately diagnose acute myocardial infarction (AMI), commonly known as a heart attack.

From Thermo Fisher Scientific Inc. 26 Oct 2009

Health IT opportunities abound, some studies question value

"The rest of the world has embraced e-mail, online forms and iPhone apps, but health care still communicates in the centuries-old technology of paper," McClatchy/Tribune News reports. Now, technology companies are recognizing a business opportunity in that shortcoming. Moving to electronic medical records can be expensive - Kaiser Permanente spent $4 billion switching from paper to digital - meaning money in the bank for well-poised vendors.

26 Oct 2009

United Treatment Centers announces partnership with Quorum Productions

United Treatment Centers Inc. announced today the partnership with Quorum Productions, Inc., a wholly-owned operating subsidiary of O2 Media, Inc. O2 Media, Inc. is a production company that is nationally renowned for creating award-winning educational programs.

26 Oct 2009

Clinical study to evaluate potential new approaches for early detection of breast cancer

U-Systems announced today that Community Hospital of the Monterey Peninsula’s Breast Care Center has initiated participation in the SOMO·INSIGHT Clinical Study.

26 Oct 2009

Axolotl launches Elysium Image Exchange

Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services, today announced the immediate availability of Elysium Image Exchange, a state-of-the-art technology integrated with Axolotl’s Elysium® Exchange suite of products. Powered by Axolotl’s partner eHealth Global Technologies, Inc. (eHGT), Elysium Image Exchange enables the electronic sharing of diagnostic quality medical images between health care providers participating in an HIE.

26 Oct 2009

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.

26 Oct 2009

Tart cherry juice may help runners recover quickly and effectively from post-race pain

From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.

26 Oct 2009

HealthSouth announces credit agreement amendment and extended maturity of a portion of its term loan

HealthSouth Corporation today announced it has amended its credit agreement and extended maturity of a portion of its term loan. A segment of the lenders under the term loan that has a current outstanding balance of approximately $750 million will extend the maturity for $300 million of that loan from March 2013 to September 2015, contingent on certain conditions.

26 Oct 2009

StayinFront signs agreements with two leading biopharma companies to deploy StayinFront EdgeRx

StayinFront, Inc., a leading global provider of CRM and decision support solutions, announced today that they have reached agreements with two leading biopharma companies to deploy StayinFront EdgeRx. Announced only recently, StayinFront EdgeRx is the new On Demand CRM and analytics solution that offers superior functionality and performance from a company that has been delivering cutting edge CRM solutions to the industry for 20 years.

26 Oct 2009

ADA Technologies to develop home lithiummonitor for patients with bipolar disorder

ADA Technologies, Inc. (ADA) received a $189,886 grant from the National Institute of Mental Health to develop a home lithiummonitor for use by patients with bipolar disorder.

26 Oct 2009

Phase 2a clinical trial in nonsense mutation hemophilia A and hemophilia B initiated

PTC Therapeutics, Inc. (PTC) today announced it is expanding the development of ataluren, an investigational new drug, to a third indication with the initiation of a Phase 2a clinical trial in nonsense mutation hemophilia A (nmHA) and hemophilia B (nmHB).

26 Oct 2009

Ontario Lung Association partners with Health Canada for radon gas awareness campaign

As winter weather approaches and we move activities indoors, it's a good time to think about the quality of the air in our homes. Radon is a colourless, odourless gas that is produced from the natural breakdown of uranium in rocks and soil. Radon can enter a home through tiny openings in floors and foundations and build up to dangerous levels. Long-term exposure to radon is the second leading cause of lung cancer in Canada.

26 Oct 2009

CMSC analyses patient self-management in Multiple Sclerosis

The Consortium of Multiple Sclerosis Centers (CMSC) released a white paper, written by a panel chaired by CMSC member Robert T. Fraser, Ph.D., of the University of Washington Rehabilitation Research and Training Center in Seattle, Washington, analyzing patient self-management in Multiple Sclerosis (MS) to develop recommendations for best practices aimed at improving patients' lives.

26 Oct 2009

Results from Phase I dose-escalation study of AT-101 announced

Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449).

26 Oct 2009

Allegheny Technologies acquires Crucible Compaction Metals and Crucible Research for $40.95 million

Allegheny Technologies Incorporated announced that it has completed the purchase of the assets of Crucible Compaction Metals and Crucible Research for $40.95 million.

26 Oct 2009

Rexahn Pharmaceuticals completes Registered Direct Offering of common stock and warrants

Rexahn Pharmaceuticals, Inc. announced today that it has completed its previously announced Registered Direct Offering of common stock and warrants. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NasdaqGM: RODM), acted as the exclusive placement agent for this transaction.

26 Oct 2009

Dysport, a new wrinkle fighter, available now in the United States

The story: Dysport(TM), a new wrinkle fighter, is now available in the United States. Dysport(TM) is a Botulinum-A enzyme like Botox Cosmetic. Dysport(TM) is positioned as the new arch-nemesis and first direct competitor of Botox Cosmetic in the United States.

26 Oct 2009

Medical News

Cardio Vascular Medical Device releases shareholders update

Wound Management Technologies signs distribution agreement with Biocure S.r.l. of Milan

Cephalon, BDC sign option agreement

Thermo Fisher Scientific announces the availability of its Copeptin assay in Europe

Health IT opportunities abound, some studies question value

United Treatment Centers announces partnership with Quorum Productions

Clinical study to evaluate potential new approaches for early detection of breast cancer

Axolotl launches Elysium Image Exchange

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

Tart cherry juice may help runners recover quickly and effectively from post-race pain

HealthSouth announces credit agreement amendment and extended maturity of a portion of its term loan

StayinFront signs agreements with two leading biopharma companies to deploy StayinFront EdgeRx

ADA Technologies to develop home lithiummonitor for patients with bipolar disorder

Phase 2a clinical trial in nonsense mutation hemophilia A and hemophilia B initiated

Ontario Lung Association partners with Health Canada for radon gas awareness campaign

CMSC analyses patient self-management in Multiple Sclerosis

Results from Phase I dose-escalation study of AT-101 announced

Allegheny Technologies acquires Crucible Compaction Metals and Crucible Research for $40.95 million

Rexahn Pharmaceuticals completes Registered Direct Offering of common stock and warrants

Dysport, a new wrinkle fighter, available now in the United States

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News